Opipharma.org

Visit opipharma.org
  • 475.1K

    Global Rank

  • 22 hours ago

    Last scanned

  • 11 years

    Domain Age

  • No data

    Daily Visitors

Opipharma.org

Visit opipharma.org

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Opipharma.org

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for opipharma.org: 54.157.24.8. Moreover, DNS used with this website include ns1.fp261.parklogic.com, ns1.parklogic.com, ns2.fp261.parklogic.com, ns2.parklogic.com. Subnet identifier ranges from 54.144.0.0 to 54.221.255.255. Classless Inter-Domain Routing (CIDR) is 54.192.0.0/12, 54.144.0.0/12, 54.220.0.0/15, 54.208.0.0/13, 54.160.0.0/11, 54.216.0.0/14. ARIN net type is Direct Allocation.

  • 475.1K

    Global Rank

  • 22 hours ago

    Last scanned

  • 11 years

    Domain Age

  • No data

    Daily Visitors

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

  • Created

    2013-02-20

  • Expires

    2025-02-20

  • Owner

    Redacted for Privacy Purposes

  • Registar

    Public Interest Registry

  • Owner Emails

    reactivation-pending@mail.withheldforprivacy.com

Domain & Keywords

The registrar of opipharma.org is Public Interest Registry and the name expires on 2025-02-20. Owner email is obscured for security reasons, so you cannot reach them directly. Their country of residence is United States of America.

  • medicine
  • مستحضرات تجميل
  • مطهرات
  • مستلزمات طبية
  • игра престолов торрент
  • ادوية بيطرية
  • اوبى فارما
  • opipharma
  • شركة العبور للصناعات الدوائية
  • تصنيع ادوية فى مصر

Opipharma.org Homepage Change Through The Years

  • What Opipharma.org website looked like in 2018 (6 years ago)

    6 years ago

    Mar 02, 2018

  • What Opipharma.org website looked like in 2018 (5 years ago)

    5 years ago

    Oct 07, 2018

  • What Opipharma.org website looked like in 2020 (4 years ago)

    4 years ago

    Feb 09, 2020

Websites similar to opipharma.org